Adults living with heart disease who eat a diet designed to support healthy gut bacteria face a lower risk of dying from any cause, according to recent analyses of nationally representative U.S. health data. Researchers used a scoring tool called the Dietary Index for Gut Microbiota, or DI-GM, which tracks 14 food components tied to microbiome health, and found that higher scores were associated with reduced all-cause and cardiovascular mortality among people with existing cardiovascular disease. The findings add a new layer to decades of research linking dietary patterns to survival after a heart disease diagnosis, but they also raise pointed questions about whether the index captures real changes in gut biology or simply reflects broader diet quality.
Why gut microbiota scores matter for heart disease survival
Heart disease remains the leading cause of death in the United States, and secondary prevention, meaning the effort to keep people alive after a diagnosis, depends heavily on medication, exercise, and diet. Most dietary guidance for these patients has centered on Mediterranean-style or plant-forward eating patterns. A study in The American Journal of Clinical Nutrition previously showed that Mediterranean-style dietary adherence was associated with lower all-cause and cardiovascular mortality among men and women with established cardiovascular disease. The DI-GM adds a different angle: instead of scoring foods by nutrient density alone, it weights them based on published evidence about their effects on gut microbial communities.
The index was built from a systematic review of diet-microbiome studies and includes 14 components, split between foods considered beneficial for gut bacteria, such as fermented dairy and high-fiber vegetables, and foods classified as unfavorable, according to a Nutrients paper that developed and validated the tool. A higher score means a person’s diet aligns more closely with patterns shown to promote microbial diversity. The practical appeal is clear: the index can be calculated from standard dietary recall data already collected in clinical surveys, which means it does not require expensive stool sampling or lab work.
The tension behind the headline is whether this scoring system actually tells clinicians something new. If DI-GM scores simply track the same eating habits already captured by the Healthy Eating Index or the Alternative Mediterranean Diet score, the index may be redundant. The National Heart, Lung, and Blood Institute has already documented that adherence to several established dietary pattern scores is linked to lower mortality risk. What makes the DI-GM distinct, at least in theory, is its explicit connection to microbial pathways, including inflammation, that could explain why certain diets protect the heart.
Mortality data from NHANES and inflammatory biomarker findings
The strongest evidence tying DI-GM to death risk in heart disease patients comes from a prospective cohort study that tested whether inflammatory biomarkers partially explain the association. Published in the Journal of Functional Foods, that analysis examined people with cardiovascular disease and reported that higher DI-GM scores were associated with reduced all-cause and cardiovascular mortality. The researchers used machine learning models alongside traditional survival analysis and found that markers of systemic inflammation accounted for a measurable share of the link between diet scores and death. This matters because it offers a biological mechanism, not just a statistical correlation, connecting what people eat to how long they survive after a cardiac event.
In that functional foods study, participants with higher gut-friendly diet scores tended to have lower levels of C-reactive protein and other circulating inflammatory markers. These biomarkers are already used clinically to gauge cardiovascular risk, so seeing them partially mediate the relationship between DI-GM and mortality strengthens the case that the index is capturing something biologically relevant. However, the mediation was only partial, suggesting that other pathways-such as blood lipid changes, blood pressure control, or improved insulin sensitivity-likely contribute as well.
A separate nationwide prospective cohort study extended the picture beyond confirmed heart disease. That analysis used data from the National Health and Nutrition Examination Survey (NHANES) spanning multiple cycles and linked participants to National Death Index records to track who died and from what cause. The study found that a gut-microbiota-favorable diet pattern was associated with lower all-cause and cardiovascular mortality across different stages of cardiovascular-kidney-metabolic syndrome, according to a large cohort analysis. Cross-sectional work using NHANES data from 2007 through 2018 also found an association between higher DI-GM scores and lower prevalence of cardiovascular disease in U.S. adults, as documented in a peer-reviewed journal article.
Mortality outcomes in these NHANES-based studies were determined through probabilistic linkage to death certificate records maintained by the National Center for Health Statistics, with cause of death coded using the International Classification of Diseases system. This method is well established but carries known limitations, including potential misclassification of cause of death and incomplete linkage for certain demographic subgroups. Even so, the consistency of findings across multiple cohorts and analytic approaches suggests that the observed associations are unlikely to be explained entirely by data-linkage errors.
Gaps between diet scores and actual gut biology
None of the mortality studies collected stool samples or measured gut microbial composition directly. The DI-GM is a proxy: it estimates microbiome-friendliness based on food intake patterns, not on sequencing data that would confirm whether a participant’s gut bacteria actually changed. This is the single largest gap in the evidence. A person could score well on the index while harboring a gut microbiome that looks nothing like what the developers of the tool envisioned, either because of genetics, medications such as antibiotics and proton pump inhibitors, or long-term dietary history that is not captured in a single 24-hour recall.
This disconnect matters for interpretation. If the DI-GM primarily reflects overall diet quality-more fiber, fewer ultra-processed foods-then its apparent benefits for people with cardiovascular disease might not be unique to the microbiome. In that scenario, the index would function as a rebranded healthy eating score, useful for risk prediction but less informative about mechanisms. On the other hand, if future work shows that higher DI-GM scores consistently correspond to richer microbial diversity, greater production of short-chain fatty acids, and reduced markers of gut permeability, then clinicians could reasonably view the index as a window into a patient’s microbial health.
Another limitation is that the DI-GM was derived mostly from observational links between specific foods and bacterial taxa, many of which are still being reclassified as microbiome science evolves. The strength and direction of these food–microbe relationships can vary across populations, depending on baseline diet, geography, and even sanitation. That raises the possibility that an index calibrated in one setting may not perform as well in another without adjustment.
What this means for patients and clinicians
For now, the practical message for adults living with heart disease is fairly straightforward. Diets that score highly on the DI-GM emphasize plant foods, whole grains, legumes, nuts, and fermented dairy, while limiting red and processed meats, refined grains, and added sugars. These patterns overlap substantially with existing heart-healthy guidelines, suggesting that patients do not need a new app or lab test to act on the current evidence. Choosing meals that support a diverse gut microbiota is likely to align with the same behaviors cardiologists have recommended for years.
Clinicians, however, may see added value in a microbiome-focused framing. Some patients are more motivated by the idea of “feeding their gut bacteria” than by abstract discussions of cholesterol or blood pressure. The DI-GM and similar tools could help translate complex microbiome science into concrete dietary advice, while also allowing researchers to test whether incremental changes in gut-friendly foods produce measurable shifts in inflammatory markers and clinical outcomes.
To move from association to causation, researchers will need randomized controlled trials that assign people with cardiovascular disease to diets differing specifically in DI-GM score, while tracking changes in microbiome composition, microbial metabolites, and hard outcomes such as hospitalization and recurrent cardiac events. Integrating stool sequencing, metabolomics, and continuous dietary monitoring would help clarify whether the index is truly capturing microbial mechanisms or simply shadowing broader lifestyle patterns.
Until those trials are completed, the emerging evidence from nationally representative cohorts offers cautious optimism. A diet that nourishes beneficial gut bacteria appears to be linked with better survival for people already living with heart disease. Whether the DI-GM ultimately becomes a clinical tool or remains primarily a research instrument, it underscores a growing consensus: what happens in the gut does not stay in the gut, and the trillions of microbes we carry may be key allies in the long fight against cardiovascular mortality.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
